Issues
- Current Issue
- Special Issues
Viewpoints
Education
Spotlight
News
Topic Compilations
On Location
Multimedia
- Sound Bites
- Meeting Coverage

Search

ASH Home
About ASH Clinical News
Authors
Advertising
Subscribe
Contact Us
eNewsletters

Cookie Settings

LOG IN

Welcome! Log into your account

Forgot your password?

Recover your password

ASH Clinical News

Issues
- All Current Issue Special Issues
  
  May 2021 Volume 7 Issue 6
  
  Focus on Myeloid Malignancies (Volume 7, Issue 6.1)
  
  April 2021 Volume 7 Issue 5
  
  March 2021 Special Edition
Viewpoints
Education
Spotlight
News
Topic Compilations
On Location
Multimedia
- Sound Bites
- Meeting Coverage

Generic selectors

Exact matches only

Exact matches only

Search in title

Search in title

Search in content

Search in content

Search in excerpt

Search in posts

Search in posts

Search in pages

Search in pages

Steven Pavletic, MD

Steven Pavletic, MD

Senior Clinician, Immune Deficiency Cellular Therapy Program, National Cancer Institute

Advertisement

Current Issue

May 2021 Volume 7 Issue 6

Saturday, May 1, 2021

This issue provides an update on gene therapies in hematology, demystifies RNA sequencing, and more.

Block title

FDA Committee Votes to Withdraw Two Accelerated Approvals of Cancer Treatments

Wednesday, May 5, 2021

Pipette Tip Shortage Hinders Scientific Work Worldwide

Wednesday, May 5, 2021

Will the FDA Crack Down on Clinical Trial Reporting Noncompliance?

Wednesday, May 5, 2021

FDA Committee Meets to Reconsider Accelerated Approvals of Cancer Drugs

Sunday, May 2, 2021

Are Survivors of Childhood Lymphomas At Increased Risk of Cognitive Impairment?

Sunday, May 2, 2021

Recent Posts

FDA Committee Votes to Withdraw Two Accelerated Approvals of Cancer Treatments
Pipette Tip Shortage Hinders Scientific Work Worldwide
Will the FDA Crack Down on Clinical Trial Reporting Noncompliance?
FDA Committee Meets to Reconsider Accelerated Approvals of Cancer Drugs

Meeting Coverage

Researchers Validate Burkitt Lymphoma Prognostic Index

Monday, March 1, 2021

Thiotepa-Containing Conditioning Regimens Improve Survival Outcomes in Patients With PCNSL

Monday, March 1, 2021

Editor's Corner

Editor’s Corner: All Those YESterdays

Saturday, May 1, 2021

Editor’s Corner: Post-Pandemia Mania

Thursday, April 1, 2021

2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545

ASH Home
Research
Education
Advocacy
Meetings
Publications
ASH Store

Copyright © 2020 by American Society of Hematology

Contact Us | Terms of Service | Privacy Policy